Comments on the EASL practice guidelines for the management of chronic hepatitis B: Controversies in interferon-based therapy

被引：3
|
作者：
Janssen, Harry L. A. [1 ]
Buster, Eric H. C. J. [1 ]
机构：
[1] Univ Med Ctr Rotterdams, Erasmus MC, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2009年 / 51卷 / 01期
关键词：
TERM-FOLLOW-UP; HBEAG-POSITIVE PATIENTS; FUMARATE TDF TREATMENT; ADV SWITCH DATA; PEGINTERFERON ALPHA-2A; LAMIVUDINE THERAPY; SUSTAINED HBEAG; VIRUS DNA; DURABILITY; SEROCONVERSION;
D O I：
10.1016/j.jhep.2009.02.012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：224 / 226
页数：3
相关论文
共 50 条
  • [41] Management of special patient groups with hepatitis B virus infection: The EASL 2017 Clinical Practice Guidelines
    Idilman, Ramazan
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2017, 28 (06): : 518 - 521
  • [42] Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C
    Murakawa, Miyako
    Asahina, Yasuhiro
    Nakagawa, Mina
    Sakamoto, Naoya
    Nitta, Sayuri
    Kusano-Kitazume, Akiko
    Watanabe, Takako
    Kawai-Kitahata, Fukiko
    Otani, Satoshi
    Taniguchi, Miki
    Goto, Fumio
    Nishimura-Sakurai, Yuki
    Itsui, Yasuhiro
    Azuma, Seishin
    Kakinuma, Sei
    Watanabe, Mamoru
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (06) : 1075 - 1084
  • [43] Pegylated interferon-based sequential therapy for treatment of HBeAg reactive pediatric chronic hepatitis B—First study in children
    Lal B.B.
    Sood V.
    Khanna R.
    Rawat D.
    Verma S.
    Alam S.
    [J]. Indian Journal of Gastroenterology, 2018, 37 (4) : 326 - 334
  • [44] Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients
    Huang, Yi-Wen
    Hu, Jui-Ting
    Hu, Fu-Chang
    Chang, Ching-Jui
    Chang, Han-Yu
    Kao, Jia-Horng
    Yang, Sien-Sing
    Chen, Ding-Shinn
    [J]. ANTIVIRAL THERAPY, 2013, 18 (04) : 567 - 573
  • [45] Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients
    Boltjes, Arjan
    Op den Brouw, Marjoleine L.
    Biesta, Paula J.
    Binda, Rekha S.
    van der Molen, Renate G.
    Boonstra, Andre
    Janssen, Harry L. A.
    Woltman, Andrea M.
    [J]. MOLECULAR IMMUNOLOGY, 2013, 53 (1-2) : 72 - 78
  • [46] Incidence of Type 2 Diabetes in Patients With Chronic Hepatitis C Receiving Interferon-Based Therapy
    Tsai, Ming-Chieh
    Kao, Kai-Liang
    Huang, Hui-Chun
    Chen, Weishan
    Fang, Chun-Kai
    Sung, Fung-Chang
    Wu, Shu-, I
    Stewart, Robert
    [J]. DIABETES CARE, 2020, 43 (06) : E63 - E64
  • [47] Patients with chronic hepatitis C who have normal ALT: A role for interferon-based therapy?
    Mark W. Russo
    Robert S. Brown
    [J]. Current Hepatitis Reports, 2003, 2 (1) : 11 - 16
  • [48] Regression of hepatic fibrosis and cirrhosis in patients with chronic hepatitis C treated with interferon-based therapy
    Metwally, MA
    Zein, CO
    Zein, NN
    [J]. GASTROENTEROLOGY, 2003, 124 (05) : 1561 - 1561
  • [49] ASSOCIATION OF INTERFERON-BASED THERAPY AND CARDIOVASCULAR DISEASE IN CHRONIC HEPATITIS C PATIENTS IN THE UNITED STATES
    Wang, W.
    Park, H.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A212 - A212
  • [50] A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance
    Mauss, S
    Berger, F
    Goelz, J
    Jacob, B
    Schmutz, G
    [J]. HEPATOLOGY, 2004, 40 (01) : 120 - 124
12345